Teriflunomide (NAT-Teriflunomide)

Immunomodulator (pyrimidine synthesis inhibitor)

Teriflunomide (NAT-Teriflunomide)

Forms and strengths
Form: TabletStrength: 14 mg
Print

Indication

  • Teriflunomide is used as a single agent (monotherapy) to treat relapsing forms of multiple sclerosis, reducing the frequency of relapses and slowing the buildup of physical disability.
  • Teriflunomide should only be prescribed by clinicians experienced in diagnosing and managing multiple sclerosis.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.